Skip to main content
. Author manuscript; available in PMC: 2011 Feb 28.
Published in final edited form as: Circ Cardiovasc Genet. 2009 Mar 30;2(3):255–259. doi: 10.1161/CIRCGENETICS.108.822320

Fig 1.

Fig 1

Fig 1

Hazard functions for fatal and non-fatal myocardial infarction by FTO genotype in those without satins (panel A) and those prescribed statins (panel B). Hazard ratios provided are adjusted for age, gender, BMI, smoking status and history of myocardial infarction